To get a 1 mg dose, you'd need to draw 0.2 mL (or 20 units)
SURPASS-2, NEJM 2021 An important caveat: semaglutides proven cardiovascular benefit is a meaningful clinical differentiator
People have lost between 15% and 21% of their starting body weight in 72 weeks
Retatrutides advantage comes from its unique triple-agonist mechanism targeting GLP-1, GIP, and glucagon receptors
Barb D, Repetto EM, Stokes ME, Shankar SS, Cusi K
The difference that matters most today, though, is regulatory: semaglutide is an approved medicine with years of real-world data, while retatrutide is still an investigational compound being studied in clinical trials